› Germany › ABX advanced biochemical compounds – Biomedizinische Forschungsreagenzien GmbH
ABX advanced biochemical compounds – Biomedizinische Forschungsreagenzien GmbH
ABX advanced biochemical compounds – Biomedizinische Forschungsreagenzien GmbH is a Private limited company (Ltd.) registered in Germany under HRB 14041 Dresden, and its current status with Handelsregister (Commercial Register) is active. Its registered address on file is Radeberg, Germany. No shareholders are recorded for ABX advanced biochemical compounds – Biomedizinische Forschungsreagenzien GmbH; ownership in this jurisdiction is normally filed as the Gesellschafterliste (shareholder list) under §40 of the GmbHG, and no such filing has been obtained for this record. No beneficial owner record is shown for ABX advanced biochemical compounds – Biomedizinische Forschungsreagenzien GmbH, as access to the German Transparenzregister is restricted to obliged entities and legitimate-interest applicants following the November 2022 CJEU ruling. This profile is sourced directly from Handelsregister (Commercial Register) and was last updated on 21 October 2026.
- Company fundamentals
- Corporate linkage & group structures
- Digitized company financials
- Firmographics — websites, social profiles, revenue and employee estimates
Officers
3
Two of the 3 officer records shown for ABX advanced biochemical compounds – Biomedizinische Forschungsreagenzien GmbH are current appointments, filed with Handelsregister (Commercial Register). Marco Thomas Muller serves as Geschäftsführer (managing director); Robert Mieth serves as Officer. The remaining 1 record shown (Peter Moll) is a former appointment that has since been resigned.
The source filing doesn't specify representation authority — whether officers can act individually or must sign jointly to bind the company — so that detail isn't available here.
Group Structure
ABX advanced biochemical compounds – Biomedizinische Forschungsreagenzien GmbH sits 4 levels below its ultimate parent, OTSUKA HOLDINGS CO., LTD., registered in Japan. The full chain up to OTSUKA HOLDINGS CO., LTD. is derived by walking shareholder filings across jurisdictions; no link in it is independently corroborated by ABX advanced biochemical compounds – Biomedizinische Forschungsreagenzien GmbH's own shareholder record.
OTSUKA HOLDINGS CO., LTD.
Japan
Get complete shareholder and officer records, ultimate beneficial owner resolution, and ongoing ownership monitoring.
Frequently Asked Questions
Who is ABX advanced biochemical compounds – Biomedizinische Forschungsreagenzien GmbH's UBO (Ultimate Beneficial Owner)?
No Ultimate Beneficial Owner (UBO) record is shown for ABX advanced biochemical compounds – Biomedizinische Forschungsreagenzien GmbH, as access to the German Transparenzregister is restricted to obliged entities and legitimate-interest applicants following the November 2022 CJEU ruling.
What is ABX advanced biochemical compounds – Biomedizinische Forschungsreagenzien GmbH's company registration number?
ABX advanced biochemical compounds – Biomedizinische Forschungsreagenzien GmbH's registration number is HRB 14041 Dresden, filed with Handelsregister (Commercial Register) in Germany. Its current status on the register is active.
Is ABX advanced biochemical compounds – Biomedizinische Forschungsreagenzien GmbH still an active company?
ABX advanced biochemical compounds – Biomedizinische Forschungsreagenzien GmbH's status on Handelsregister (Commercial Register) is listed as active.
What is ABX advanced biochemical compounds – Biomedizinische Forschungsreagenzien GmbH's registered address?
The registered address on file for ABX advanced biochemical compounds – Biomedizinische Forschungsreagenzien GmbH is Radeberg, Germany.
Who are the officers/directors of ABX advanced biochemical compounds – Biomedizinische Forschungsreagenzien GmbH?
Two of the 3 officer records shown for ABX advanced biochemical compounds – Biomedizinische Forschungsreagenzien GmbH are current appointments, filed with Handelsregister (Commercial Register). Marco Thomas Muller serves as Geschäftsführer (managing director); Robert Mieth serves as Officer. The remaining 1 record shown (Peter Moll) is a former appointment that has since been resigned.
Does ABX advanced biochemical compounds – Biomedizinische Forschungsreagenzien GmbH have a parent company or subsidiaries?
ABX advanced biochemical compounds – Biomedizinische Forschungsreagenzien GmbH sits 4 levels below its ultimate parent, OTSUKA HOLDINGS CO., LTD., registered in Japan.
Can Zavia monitor changes to ABX advanced biochemical compounds – Biomedizinische Forschungsreagenzien GmbH's ownership over time?
This profile reflects a point-in-time snapshot from Handelsregister (Commercial Register). Zavia's monitoring API can track changes to ABX advanced biochemical compounds – Biomedizinische Forschungsreagenzien GmbH's registered shareholders, officers, and group structure going forward, flagging updates as they're filed rather than requiring a manual recheck.
Can I access ABX advanced biochemical compounds – Biomedizinische Forschungsreagenzien GmbH's data through an API?
Yes. Zavia's API connects directly to official government ownership registries across 195 countries and territories, including Germany, so records like ABX advanced biochemical compounds – Biomedizinische Forschungsreagenzien GmbH's registration, shareholder, UBO, and group-structure data can be queried programmatically instead of viewed one page at a time.
Where does this company information come from, and how current is it?
This record is sourced directly from Handelsregister (Commercial Register) and was last synced on 21 October 2026.